Status:

COMPLETED

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions:

Dry Eye Disease (DED)

Asthenopia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

At present, research on cyclosporine mainly focuses on patients with moderate to severe dry eye. Based on the importance of the vicious cycle of inflammation in the pathogenesis of dry eye and the mec...

Eligibility Criteria

Inclusion

  • 18-75 years old (including 18 and 75 years old), male or female;
  • Meets the diagnostic criteria for dry eye syndrome in China (2020) and is mild dry eye 1) Dry Eye Questionnaire (OSDI) score ≥ 13 points; 2) BUT ≤ 10 seconds or Schirmer I ≤ 5mm/5 minutes 3) Corneal staining positive ≤ 5 points.
  • At least one of OSDI, BUT, and Schirmer I meets the moderate standard OSDI ≥ 23 points; BUT\<5 seconds; Schirmer I \< 5mm/5min
  • The subjects themselves signed an informed consent form and voluntarily participated in this study.

Exclusion

  • Women who are breastfeeding or pregnant, or men and women of childbearing age who are unable to use effective contraceptive methods during the study period;
  • Those who need to wear contact lenses during treatment;
  • Acute inflammation, infection, allergy, and trauma of the eyes;
  • There are obvious scars or keratinization on the eyelid margin;
  • Have undergone eye or eyelid surgery within the 6 months prior to enrollment;
  • Diagnosed with facial nerve paralysis or ocular nerve paralysis within 6 months prior to enrollment;
  • Currently using lacrimal duct embolization (permanent lacrimal plug or treatment with lacrimal plug within 6 months);
  • I am currently taking medication that may affect dry eye syndrome.

Key Trial Info

Start Date :

November 18 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 14 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06981104

Start Date

November 18 2024

End Date

February 14 2025

Last Update

November 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

1 Xihu Avenue, Shangcheng District, Hangzhou, Zhejiang, China

Hangzhou, Zhejiang, China

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT | DecenTrialz